Ethnoracial Inclusion in Clinical Trials of Ketamine in the Treatment of Mental Health Disorders
Journal of Studies on Alcohol and Drugs July 1, 2022 Timothy I. Michaels, Lebert Lester, Sara de la Salle et al. 19 citations
OBJECTIVE: Despite strong evidence for the safety and efficacy of ketamine in the treatment of mood disorders, the enrollment of Black, Indigenous, and People of Color (BIPOC) has not been a focus of this research. Health disparities in the treatment of mood disorders in BIPOC indicate a strong need to understand the clinical, social, and pharmacological aspects of this novel treatment in...